Access to Medicine Quotes

Life expectancy in many parts of Africa can be something around the age of thirty five to thirty eight. I mean you're very fortunate if you live to that age. In fact when I went to Uganda for the first time one of the things that occurred to me was that I saw very few elderly people.

No one should have to choose between taking lifesaving medicine and paying for food.

It's easy to complain that pharmaceutical companies place profits over people and apparently care more about hair loss than TB. However, many in the pharmaceutical industry would be glad for the opportunity to reorient their research toward medicines that are truly needed, provided only that such research is financially sustainable.

The IP standards advanced countries favour typically are designed not to maximise innovation and scientific progress, but to maximise the profits of big pharmaceutical companies and others able to sway trade negotiations.

Throughout our history we have been tireless advocates for expanding access to high-quality, affordable medicine. This is especially true in the area of HIV/AIDS.

It's OK for China to invent cancer drugs that cure patients in the United States. We want them to catch up. But as the leader, we want to keep setting a very, very high standard. We don't want them to catch up because we're slowing down or, even worse, going into reverse.

I have successfully challenged the Western world's existing model of pharmaceutical innovation, which leads to the creation of monopolistic markets for novel, life-saving drugs that deliver high margins at low volumes.

I believe that life-saving, essential drugs should be freely available and the innovator should be paid a suitable royalty payment for his invention.

If you look at the world's top 50 drugs being sold today, they are being marketed and sold by companies that did not invent them. I respect patents. I'll pay a royalty. But I shouldn't be denied the right to produce drugs for poor people at reasonable prices.

I'm the cofounder of Keep a Child Alive. We provide medicine for families affected by HIV and AIDS in places like Africa and India.

Biocon is on a journey of making impact on global healthcare. I have to make sure that I have one in five persons who needs insulin therapy to use a Biocon product - that is my dream.

Sometimes in this whole Medicare prescription drug debate, we focus on the prescription drug benefit, and I am glad we do because it is the first time we have ever offered real help to seniors, especially the poor, those in need.

People shouldn't be forced to chose between paying for rent or paying for medication. They deserve a government ready to take on Big Pharma by implementing health coverage, starting by extending pharmacare coverage to every Canadian.

The first and pivotal negotiations over global access to AIDS drugs began in Geneva in 1991. They lasted two years, but confidential minutes suggest they were doomed the first day.

For a decade, makers of AIDS medicines had rejected the idea of lowering prices in poor countries for fear of eroding profits in rich ones. The position required a balancing act, because the companies had to deflect attacks on the global reach of their patents, which granted exclusive marketing rights for antiretroviral drugs.

My priorities are a fair trade policy in this country, increasing the minimum wage, going after the drug companies for the way that they charge and their whole pricing structure that have put absolutely amazing drugs out of reach for so many Americans.

There is no governing structure for a pandemic, and little more than vague political pressure to ensure limited access to life-sparing tools and medicines for more than half the world population.

Africa is a nation that suffers from incredible disease.

One problem I have with drug companies is that they don't make all their data public.

We know Africa does not have the same medical treatments as we do.

There are no issues more personal than prescription drugs and the high prices Americans must pay to get the medicine they need.

If you look at three diseases, the three major killers, HIV, tuberculosis and malaria, the only disease for which we have really good drugs is HIV. And it's very simple: because there's a market in the United States and Europe.

Drug manufacturers could afford to sell AIDS drugs in Africa at virtually any discount. The companies said they did not do so because Africa lacked the requisite infrastructure.

Scores of Congolese die each day unnecessarily due to the lack of access to healthcare and modern medicine.

It is clear that the pharmaceutical industry is not, by any stretch of the imagination, doing enough to ensure that the poor have access to adequate medical care.